Levetiracetam Alter (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a crucial role in regulating neurotransmitter release. By modulating this protein, the drug stabilizes neuronal firing and diminishes excessive excitability, thereby lowering the likelihood of seizure generation.

The dosage of Levetiracetam Alter is individualized by the prescribing clinician based on the patient’s age, type of seizure, renal function, and response to therapy. The prescriber determines the appropriate starting dose and any subsequent titration schedule.

Levetiracetam’s pregnancy category is listed as unknown, indicating limited data on fetal risk. Healthcare providers must weigh the potential benefits against possible risks. Breastfeeding mothers should consult their physician, as the drug can be excreted in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or phenytoin, levetiracetam has a distinct mechanism (SV2A binding) and generally fewer drug‑enzyme interactions. It is often preferred when a simpler dosing regimen or a lower interaction profile is desired, though individual response varies.

Levetiracetam Alter should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Levetiracetam Alter is taken orally, with or without food, as directed by the prescriber. Tablets (or the appropriate oral formulation) should be swallowed whole with water unless otherwise instructed.

Serious adverse events include severe skin reactions (e.g., Stevens‑Johnson syndrome), significant mood changes such as depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, mood swings, or signs of infection.

Levetiracetam Alter is contraindicated in individuals with a known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment who have not had dose adjustments, and for those with a history of serious psychiatric disorders.